Skip to main content
. 2018 Oct 24;62(11):e00948-18. doi: 10.1128/AAC.00948-18

FIG 2.

FIG 2

Observed zidebactam (ZID) free plasma and epithelial lining fluid (ELF) concentrations in the neutropenic lung infection model following dosing of the zidebactam human-simulated regimen (22.5 mg/kg at 0 h, 4.5 mg/kg at 2 h, 2.5 mg/kg at 4 h, and 1.5 mg/kg at 6 h, every 8 h) and the cefepime human-simulated regimen compared with the simulated human zidebactam exposure following a 1-g 1-hour intravenous infusion.